Literature DB >> 24554399

Computed tomography findings in liver fibrosis and cirrhosis.

A Huber1, L Ebner, M Montani, N Semmo, K Roy Choudhury, J Heverhagen, A Christe.   

Abstract

PRINCIPLES: Computed tomography (CT) is inferior to the fibroscan and laboratory testing in the noninvasive diagnosis of liver fibrosis. On the other hand, CT is a frequently used diagnostic tool in modern medicine. The auxiliary finding of clinically occult liver fibrosis in CT scans could result in an earlier diagnosis. The aim of this study was to analyse quantifiable direct signs of liver remodelling in CT scans to depict liver fibrosis in a precirrhotic stage.
METHODS: Retrospective review of 148 abdominal CT scans (80 liver cirrhosis, 35 precirrhotic fibrosis and 33 control patients). Fibrosis and cirrhosis were histologically proven. The diameters of the three main hepatic veins were measured 1-2 cm before their aperture into the inferior caval vein. The width of the caudate and the right hepatic lobe were divided, and measured horizontally at the level of the first bifurcation of the right portal vein in axial planes (caudate-right-lobe ratio). A combination of both (sum of liver vein diameters divided by the caudate-right lobe ratio) was defined as the ld/crl ratio. These metrics were analysed for the detection of liver fibrosis and cirrhosis.
RESULTS: An ld/crl-r <24 showed a sensitivity of 83% and a specificity of 76% for precirrhotic liver fibrosis. Liver cirrhosis could be detected with a sensitivity of 88% and a specificity of 82% if ld/crl-r <20.
CONCLUSION: An ld/crl-r <24 justifies laboratory testing and a fibroscan. This could bring forward the diagnosis and patients would profit from early treatment in a potentially reversible stage of disease.

Entities:  

Mesh:

Year:  2014        PMID: 24554399     DOI: 10.4414/smw.2014.13923

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  11 in total

1.  Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis.

Authors:  Perry J Pickhardt; Kyle Malecki; Oliver F Hunt; Claire Beaumont; John Kloke; Timothy J Ziemlewicz; Meghan G Lubner
Journal:  Eur Radiol       Date:  2016-11-17       Impact factor: 5.315

Review 2.  Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy.

Authors:  Pallavi Pandey; Ankur Pandey; Mary Dillhoff; Carl Schmidt; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-09-18       Impact factor: 3.452

3.  Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.

Authors:  Gamal Shiha; Alaa Ibrahim; Ahmed Helmy; Shiv Kumar Sarin; Masao Omata; Ashish Kumar; David Bernstien; Hitushi Maruyama; Vivek Saraswat; Yogesh Chawla; Saeed Hamid; Zaigham Abbas; Pierre Bedossa; Puja Sakhuja; Mamun Elmahatab; Seng Gee Lim; Laurentius Lesmana; Jose Sollano; Ji-Dong Jia; Bahaa Abbas; Ashraf Omar; Barjesh Sharma; Diana Payawal; Ahmed Abdallah; Abdelhamid Serwah; Abdelkhalek Hamed; Aly Elsayed; Amany AbdelMaqsod; Tarek Hassanein; Ahmed Ihab; Hamsik GHaziuan; Nizar Zein; Manoj Kumar
Journal:  Hepatol Int       Date:  2016-10-06       Impact factor: 6.047

4.  The diagnosis of hepatic fibrosis by magnetic resonance and near-infrared imaging using dual-modality nanoparticles.

Authors:  Yunfang Li; Wenting Shang; Xiaoyuan Liang; Chaoting Zeng; Mingming Liu; Sudan Wang; Hongjun Li; Jie Tian
Journal:  RSC Adv       Date:  2018-02-12       Impact factor: 4.036

5.  T1 mapping of the liver and the spleen in patients with liver fibrosis-does normalization to the blood pool increase the predictive value?

Authors:  Verena Carola Obmann; Annalisa Berzigotti; Damiano Catucci; Lukas Ebner; Christoph Gräni; Johannes Thomas Heverhagen; Andreas Christe; Adrian Thomas Huber
Journal:  Eur Radiol       Date:  2020-12-11       Impact factor: 5.315

6.  Computed tomography (CT) and magnetic resonance imaging (MRI) of diffuse liver disease: a multiparametric predictive modelling algorithm can aid categorization of liver parenchyma.

Authors:  Ricardo Donners; Carmen Zaugg; Julian E Gehweiler; Tuyana Boldanova; Markus H Heim; Luigi M Terracciano; Daniel T Boll
Journal:  Quant Imaging Med Surg       Date:  2022-02

7.  CT texture analysis of the liver for assessing hepatic fibrosis in patients with hepatitis C virus.

Authors:  Meghan G Lubner; Daniel Jones; John Kloke; Adnan Said; Perry J Pickhardt
Journal:  Br J Radiol       Date:  2018-10-11       Impact factor: 3.039

Review 8.  State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives.

Authors:  Adrian Huber; Lukas Ebner; Johannes T Heverhagen; Andreas Christe
Journal:  Eur J Radiol Open       Date:  2015-05-26

9.  CT predicts liver fibrosis: Prospective evaluation of morphology- and attenuation-based quantitative scores in routine portal venous abdominal scans.

Authors:  Verena C Obmann; Nando Mertineit; Annalisa Berzigotti; Christina Marx; Lukas Ebner; Roland Kreis; Peter Vermathen; Johannes T Heverhagen; Andreas Christe; Adrian T Huber
Journal:  PLoS One       Date:  2018-07-10       Impact factor: 3.240

10.  Liver Remodeling on CT Examination in Patients with HCV Compensated Cirrhosis Who Achieved Sustained Virological Response after Direct-Acting Antivirals Treatment.

Authors:  Florin Mihai; Anca Trifan; Carol Stanciu; Ana Maria Singeap; Bogdan Cucuteanu; Corina Lupascu Ursulescu; Corina Pop; Irina Girleanu; Tudor Cuciureanu; Dragos Negru; Camelia Cojocariu
Journal:  Medicina (Kaunas)       Date:  2020-04-10       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.